<b>Background/Objectives</b>: Nusinersen is a synthetic antisense RNA oligonucleotide employed in the management of spinal muscular atrophy, a rare neuromuscular disorder, by modulating the alternative splicing of the survival motor neuron 2 (SMN2) gene. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.